云开药网品牌怎么样 申请店铺

我要投票 云开药网在网上药店行业中的票数:150 更新时间:2025-04-02
云开药网是哪个国家的品牌?「云开药网」是 浙江云开亚美大药房连锁有限公司 旗下著名品牌。该品牌发源于浙江,由创始人刘云江在2012-01-05期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力云开药网品牌出海!通过在本页面挂载云开药网品牌的产品链接和联系邮箱,可以提高云开药网产品曝光!跨境电商爆单神器,目前只要100元/年哦~

云开药网怎么样

浙江云开亚美医药科技股份有限公司(以下简称云开亚美),成立于2011年,上市公司海正药业(股票代码600267)控股企业。是国内领先的重大慢性疾病用药连锁专科药房,旗下有浙江云开亚美大药房连锁有限公司、上海云开亚美大药房有限公司、上海医度迅健康咨询有限公司三大子公司,以经营专科药品为特色,是一家集网上药店、高端连锁、专业药师服务为一体的优秀的医药电商企业,志于打造成为中国专业的医药电子商务零售平台。

云开亚美作为一个针对重大慢性疾病用药的高端零售品牌,专营重大慢特疾病用药及产品(包括药品,保健品,医疗器械等),并基于强大的数据库管理能力和专业的药师服务团队,致力于为客户提供持续、专业的疾病管理服务。

从建立以来,云开亚美一直专注于重大慢性特殊疾病领域,专营慢特疾病用药及产品(包括药品,保健品,医疗器械等),并以专业的医药学知识和真诚服务,基于患者数据库管理,致力于为客户提供持续、专业的疾病管理服务,以人为本的服务理念获得顾客信赖。

所有药师都具有药学专业资格证书,其中拥有执业药师资格占30%,具有扎实的医药基础、优秀的职业素养并在各自领域积累了特有的丰富专科用药知识和经验,致力于提供专业、专精的服务

数十位专业药师免费在线咨询,量身定做电子药历,全程指导用药,并在饮食、运动、日常保健注意等方面给以合理、贴心的专业指导。不仅保证患者可以坚持正确的用药过程,在日常生活各个方面也是遵照科学的方法给予指导,帮助患者全面保持健康。

截止2016年6月,云开亚美已在互联网全渠道建设部署,包括自建交易电商平台(云开药网|无线网店|云开掌上药店APP)、第三方平台旗舰店(天猫、京东、一号店、818、八百方、京卫药房网等)、社交交易平台(微信交易账户网店、支付宝服务窗交易账号网店等),已形成了良好的口碑效应

云开亚美积累了近40种慢特疾病近2000万的慢特疾病患者数据,尤其在股骨头坏死、糖尿病、慢性肾病、慢性肝病等领域极具优势。

云开亚美采用独有的DTC(DirectToConsumer)患教平台,面向慢性特殊疾病终端患者,以数以千万级的详实的患者数据库为核心,通过DTC网站、呼叫中心、短信平台、直邮平台、患者俱乐部及网络互动六大信息沟通渠道,为患者提供国际领先的疾病贴身服务。

专业IT技术团队20人,自建独立订单系统EC-ERP、专业客服接待/呼叫系统、CRM用户管理系统、大型专业物流仓储系统,系统自动跟踪订单、管理后台数据化呈现,用户全程实时跟踪更清晰、更直观、更简单。


Zhejiang Yunkai Yamei Pharmaceutical Technology Co., Ltd. (hereinafter referred to as Yunkai Yamei), founded in 2011, is a holding enterprise of Haizheng Pharmaceutical (Stock Code: 600267). It is a leading chain specialty pharmacy for major chronic diseases in China. It has three subsidiaries, namely Zhejiang Yunkai Yamei pharmacy chain Co., Ltd., Shanghai Yunkai Yamei pharmacy Co., Ltd. and Shanghai yiduxun Health Consulting Co., Ltd. It is an excellent pharmaceutical e-commerce enterprise integrating online pharmacy, high-end chain and professional pharmacist services with the characteristics of specialized drugs The company aims to build a professional pharmaceutical e-commerce retail platform in China. As a high-end retail brand for major chronic disease drugs, Yunkai Yamei specializes in major chronic disease drugs and products (including drugs, health products, medical devices, etc.), and is committed to providing customers with continuous and professional disease management services based on strong database management ability and professional pharmacist service team. Since its establishment, Yunkai Yamei has been focusing on the field of major chronic special diseases, specializing in drugs and products for chronic special diseases (including drugs, health care products, medical devices, etc.), providing continuous and professional disease management services for customers based on professional medical knowledge and sincere service, patient database management, and people-oriented service concept to win customers' trust 。 All pharmacists have pharmaceutical professional qualification certificates, of which 30% are licensed pharmacists. They have solid medical foundation, excellent professional quality and have accumulated unique and rich specialized drug knowledge and experience in their respective fields. They are committed to providing professional and professional services for dozens of professional pharmacists, free online consultation, customized electronic drug calendar, guiding drug use in the whole process, and drinking Food, sports, daily health care and other aspects to give reasonable and thoughtful professional guidance. Not only to ensure that patients can adhere to the correct medication process, in all aspects of daily life is also in accordance with scientific methods to give guidance to help patients to maintain overall health. As of June 2016, Yun Kai Asia and the United States have already deployed in the whole channel of the Internet, including self built trading platform (cloud pharmaceutical network, wireless Internet store, cloud open pocket pharmacy APP), third party platform flagship store (Tmall, Jingdong, No. 1 store, 818, eight hundred party, Jingwei pharmacy network, etc.), social trading platform (WeChat trading account shop, Alipay service window, transaction account shop, etc.) It has formed a good word-of-mouth effect. Yunkai Yamei has accumulated data of nearly 20 million patients with 40 kinds of chronic diseases, especially in the areas of femoral head necrosis, diabetes, chronic kidney disease, chronic liver disease and so on. Yunkai Yamei adopts the unique DTC (directtoconsumer) patient education platform for the terminal patients with chronic special diseases. With tens of millions of detailed patient databases as the core, it provides the patients with the world's leading disease intimate service through six information communication channels: DTC website, call center, SMS platform, direct mail platform, patient club and network interaction. There are 20 professional IT technical teams, with independent order system EC-ERP, professional customer service reception / call system, CRM user management system and large-scale professional logistics storage system. The system automatically tracks orders and manages the background data presentation. The real-time tracking of users is clearer, more intuitive and simpler.

本文链接: https://brand.waitui.com/30598aa74.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

三大指数全线翻绿

36氪获悉,截至发稿,指数冲高回落,三大指数午后继续回落并翻绿,创业板指早盘一度涨近1%,贵金属、可控核聚变、军工等方向跌幅居前。

12分钟前

涂鸦智能前CFO刘尧加入硬件公司xTool

36氪独家获悉,涂鸦智能前CFO刘尧已加入深圳激光雕刻机创业公司xTool,负责财务及部分经营工作。据了解,2024年,xTool营收在20亿到30亿元之间。截至发稿,xTool未对此消息作出回应。

12分钟前

北京支持商业企业升级改造,单个项目补助金额最高500万元

36氪获悉,北京市商务局发布“关于征集2025年支持商场、商街、商圈品质提升项目的通知”,其中提到,北京对全市商场、商街、商圈品质提升项目将给予资金支持。其中,支持商业企业升级改造,单个项目最高补助金额500万元。

12分钟前

美国股市创两年多来最差季度表现

受贸易紧张局势持续打压市场人气等多重因素影响,今年一季度美国股市创下两年多来最差季度表现。纽约股市纳斯达克综合指数一季度累计下跌10.4%,为2022年二季度以来最大单季跌幅;标准普尔500种股票指数一季度累计跌幅为4.6%,为2022年三季度以来表现最差的一个季度。(新华社)

12分钟前

永辉上海学习胖东来调改二店开业

36氪获悉,4月2日,永辉超市上海第二家“学习胖东来”自主调改店——浦江万达广场店焕新开业。作为闵行区首家调改门店,其以“环境焕新+商品升级+服务进阶+员工关怀”的崭新面貌登场,不仅是永辉全国调改版图的又一落子,更为上海建设国际消费中心城市注入新动能。据了解,该店开业后,永辉全国调改门店数量将攀升至48家,预计在今年年中调改门店将达100家,全年达200家。

12分钟前

本页详细列出关于怀仁大药房的品牌信息,含品牌所属公司介绍,怀仁大药房所处行业的品牌地位及优势。
咨询